Mcmorgan & CO LLC Medpace Holdings, Inc. Transaction History

Mcmorgan & CO LLC

$578 Million
Q1 2024

A detailed history of Mcmorgan & CO LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Mcmorgan & CO LLC holds 9,197 shares of MEDP stock, worth $3.79 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

9,197

Previous 9,233 0.39%

Holding current value

$3.79 Million

Previous $2.83 Million 31.31%

% of portfolio

0.64%

Previous 0.47%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $10,255 - $14,879	-36 Reduced 0.39%	9,197 $3.72 Million
Q4 2023 Feb 13, 2024	BUY	$227.52 - $312.68 $60,292 - $82,860	265 Added 2.95%	9,233 $2.83 Million
Q3 2023 Nov 13, 2023	SELL	$233.98 - $281.67 $303,472 - $365,325	-1,297 Reduced 12.64%	8,968 $2.17 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $124,527 - $159,713	665 Added 6.93%	10,265 $2.47 Million
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $24,752 - $34,011	-142 Reduced 1.46%	9,600 $1.81 Million

Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $348,670 - $516,126	-2,278 Reduced 18.95%	9,742 $2.07 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $46,441 - $58,396	-320 Reduced 2.59%	12,020 $1.89 Million
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $865,829 - $1.12 Million	6,650 Added 116.87%	12,340 $1.85 Million
Q1 2022 May 17, 2022	SELL	$138.87 - $214.31 $23,607 - $36,432	-170 Reduced 2.9%	5,690 $930,000
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $184,567 - $230,179	1,010 Added 20.82%	5,860 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$170.18 - $198.21 $825,373 - $961,318	4,850 New	4,850 $918,000

Others Institutions Holding MEDP

# of Institutions

622

Shares Held

25.1M

Call Options Held

154K

Put Options Held

117K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcmorgan & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcmorgan & CO LLC with notifications on news.

Account